The startup offers an air and surface disinfection system utilizing tube bipolar ionization technology, designed for buildings of any size. This system effectively reduces airborne and surface pathogens, enhancing indoor air quality and safety for occupants.
Funding
$300K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Many buildings lack effective air and surface disinfection systems, leading to the spread of airborne and surface pathogens. This can result in poor indoor air quality, increased risk of infections, and health concerns for building occupants.
Solution
This startup provides an air and surface disinfection system that utilizes tube bipolar ionization (TBI) technology to reduce pathogens in buildings. The system is designed to be scalable for buildings of any size, improving indoor air quality and creating a safer environment for occupants by actively neutralizing airborne and surface contaminants. By implementing TBI, the system aims to provide continuous disinfection, reducing the reliance on traditional cleaning methods and promoting a healthier indoor space.
Target Audience
The primary target audience includes building owners, facility managers, and businesses seeking to improve indoor air quality and create healthier environments for occupants.
Features
- Tube bipolar ionization (TBI) technology for pathogen reduction
- Scalable design suitable for various building sizes
- Continuous air and surface disinfection
- Proactive neutralization of airborne and surface contaminants